|
Bratilova E.S., Kachnov V.A., Tyrenko V.V., Afonaskov O.V.
Predictors of cardiovascular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults
|
№1 / 2023
|
|
Anikin D.A., Solovieva I.A., Demko I.V., Sobko E.A., Gordeeva N.V., Kraposhina A.Yu.
Peculiarities of the association of bronchial asthma with obesity depending on the time of asthma debut and the possibilities of cardiovascular risk prediction in this group of patients
|
№10 / 2022
|
|
Martynov A.I., Demidova T.Yu., Balan V.E., Adasheva T.V., Tapilskaya N.I., Moskvicheva Yu.B., Kuznetsova P.I., Balan P.V.
Resolution of the Interdisciplinary Expert Council «Management of metabolic health as the basis of age-related diseases. Focus on active longevity»
|
№8 / 2022
|
|
Demidova T.Yu., Korotkova T.N., Kochina A.S.
Influence of dietary fiber on metabolism of gut microbiota and carbohydrate metabolism
|
№8 / 2022
|
|
Tarzimanova A.I.
Obesity and atrial fibrillation: mechanisms of occurence and current treatment guidelines
|
№7 / 2022
|
|
Lagutina S.N., Zuikova A.A., Dobrynina I.S., Kotova Yu.A.
Assessment of the biodiversity of the intestinal microbiota as a new diagnostic sign of metabolic disorders
|
№4 (приложение) / 2022
|
|
Kucherenko N.G., Bebekh A.N., Umarova I.A., Gorelov A.I.
Dyspnoea and respiratory mechanics disturbances in obesity patients
|
№8 / 2021
|
|
Larina V.N., Bondarenkova A.A.
Clinical observation of a young patient with obesity and COVID-19-associated lung tissue damage
|
№8 / 2020
|
|
Granovskaya M.V., Demidova T.Yu., Zaslavskaya K.Ya., Balykova L.A.
Targeted therapy of COVID-19 in ambulatory-polyclinical practice
|
№8 / 2020
|
|
Volkova A.R., Fishman M.B., Semikova G.V, Somova V.M., Mozgunova V.S.
Clinical predictors of weight regain after bariatric surgery
|
№8 / 2020
|
|
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V.
Kidney damage in case of obesity: variants of clinical course, mechanisms of development
|
№6 / 2019
|
|
Ametov A.S., Rubtsov Yu.E., Saluhov V.V., Khalimov Yu.Sh., Agafonov P.V.
Elimination of adipose tissue dysfunction as a major factor in reducing cardiometabolic risks in obesity
|
№6 / 2019
|
Русский
